CII
GEVA

CR Intrinsic Investors’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

CR Intrinsic Investors’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-10,000
Closed -$633K – 418
2013
Q3 		$633K Sell
10,000
-108,161
-92% -$6.85M 0.02% 299
2013
Q2 		$4.96M Buy
+118,161
New +$4.96M 0.17% 171